Rat EGFR quantitates rat EGFR in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat EGFR.
Rat EGFR quantitates rat EGFR in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rat EGFR.
The EGFR gene on chromosome 7 in humans encoded L-EGFR (epidermal growth factor receptor, HER1, ErbB1). The EEGFR belongs to the HER/ERbB protein family, which includes three other tyrosine kinase receptors, ERbB2, ERbB3, ERbB4. The EGFR is a transmembrane receptor and the binding of its cognized ligands such as the EGF (epidermal growth factor) and the alpha TGF (alpha transformation growth factor) to the extracellular domain leads to the dimerization of the EGFR followed by the autophosphorylation of the tyrosine residues in the cytoplasmic domain. The phosphorylation of the EGFR to certain residues is also induced by the Src-non-receptor kinase. The activation of the EGFR allows several downstream signal cascades such as the Ras - ERK, PI3-K - Akt, Jak - STAT and PKC pathways that contribute to cell growth and proliferation. The phosphorylation of the EGFR to Y1086 allows inter alia the binding of the GRB2 adaptor protein, leading to the activation of the MAPK pathway. During activation and signalling of receptors, the EGFR is endocytotic and targeted for degradation or recycling. Mutations in the EGFR gene are associated with lung cancer and several alternative-spinning transcription variants encoding different protein isoforms of the EGFR have been found. Increased production or activation of EGFR was associated with poor prognosis on a variety of tumours. In addition, the overexpression of EGFR is observed in tumours of the head and neck, brain, bladder, stomach, breast, lung, endometrium, cervix, vulva, ovary, esophagus, stomach, and epidermoid carcinoma.
Sensitivity
Sensitivity of dosage: 23 pg/ml.
Measurement range
Dose range: 23 to 5,000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Sample type: Plasma, Serum, Surnatant (plasma volume, 50 µl; supernatant, 50 µl; serum, 50 µl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17115849 |
| Specifications |
| Accession number | 2.7.10.1; 9030024J15Rik; AI552599; Viral erythroblast leukaemia (v-erbB); Viral erythroblast leukaemia (v-erb-b) counterpart; Cell growth inhibitor protein 40; cell proliferation inducer protein 61; EC 2.7.10 |
| Dose range | 23 to 5 000 pg/ml |
| Sensitivity of the dosage | 23 pg/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Gene symbol(s) | EGFR |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | EGFR |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 µl; supernatant, 50 µl; serum, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | ERA10RBX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.